GlassScriptPhysician profile
Frank D Russo
NPI 1225369648
$7,695.97
in general payments reported to CMS, 2019-2025
23 companies · $1,140 in 2025
The $1,140 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,453 · 2020: $282 · 2021: $462 · 2022: $505 · 2023: $2,176 · 2024: $678 · 2025: $1,140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,365 · Travel and Lodging: $1,629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,364.80 |
| Travel and Lodging | $1,629.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,856.56 | 2021-2025 | Amplia Mri Quad Crt-D Surescan, Attain Command + Surevalve, Micra |
| Boston Scientific Corporation | $2,186.59 | 2019-2025 | Rotapro, Avvigo Guidance System, Rotablator Rotational Atherectomy System Console Kit |
| Medtronic Vascular, INC. | $797.97 | 2019-2020 | |
| Abiomed | $420.01 | 2022-2025 | Impella |
| Corindus INC. | $329.12 | 2019 | |
| Atricure, INC. | $153.85 | 2024 | |
| Amgen INC. | $132.11 | 2020-2024 | Repatha, Tezspire |
| Abbott Laboratories | $126.61 | 2019-2022 | |
| Terumo Medical Corporation | $115.95 | 2021 | |
| Surmodics, INC. | $115.60 | 2024 | Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| Siemens Medical Solutions USA, INC. | $104.35 | 2019 | |
| Merck Sharp & Dohme LLC | $69.23 | 2022-2023 | Verquvo |
| Impulse Dynamics (USA) INC. | $56.34 | 2021 | |
| Pfizer INC. | $35.76 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $32.73 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $31.16 | 2022-2025 | |
| United Therapeutics Corporation | $25.53 | 2024 | Tyvaso |
| Acacia Pharma INC | $24.31 | 2022 | |
| Chiesi USA, INC. | $17.50 | 2025 | Cleviprex, Kengreal |
| Braemar Manufacturing, LLC | $17.14 | 2019 | |
| Sunovion Pharmaceuticals INC. | $16.05 | 2019 | |
| Advanced Oxygen Therapy INC. | $15.89 | 2025 | Topical Oxygen Chamber For Extremities |
| Astrazeneca Pharmaceuticals LP | $15.61 | 2023 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Russo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.